Portfolio News

New multi-cancer early detection blood test study opens

The University of Oxford has opened a new study, which will trial a new multi-cancer early detection (MCED) blood test for early detection of more than 50 types of cancer. The study, SYMPLIFY, is also open at Oxford University Hospitals (OUH) and already includes more than 500 participants. That number could double by the end of the trial. The research team is supported by the NIHR Oxford Biomedical Research Centre, which is currently recruiting about 6,000 patients to participate in a trial of the Galleri blood...

Inspired by Airbnb, Hims & Hers offers 10,000 free medical visits to displaced Afghan refugees

Our portfolio company, Hims & Hers, is in the process of distributing 10,000 free primary care and mental health visits to displaced Afghan refugees. According to a post on the company blog, Hims & Hers plans to coordinate with select non-governmental organizations and other relevant partners, including the providers on our platform, to make sure these refugees are aware of these services and get the support they need. The visits are immediately available to refugees. “We feel a moral responsibility to act—and fast,” Dudum wrote in the...

AllStripes Raises $50 million to support rare disease research

AllStripes recently closed a $50 million Series B funding round led by Lux Capital, with participation from McKesson Ventures, JAZZ Venture Partners, Spark Capital, Medidata Solutions (a Dassault Systèmes company), and Maveron, along with angel investors including Arif Nathoo, CEO of McKesson Ventures portfolio company Komodo Health; and Leila Zegna, director of the Kabuki Syndrome Foundation. AllStripes, formerly known as RDMD was founded in 2017 by Nancy Yu, who had previously been in corporate development for 23andMe; and Onno Faber, a developer who was diagnosed with...

Investors Pouring Billions into Digital Health Ventures

As COVID-19 has caused a sea change in healthcare, with the rapid expansion of virtual healthcare and telemedicine, investors have been busy pouring their dollars into the digital health space. In fact, between January and June of 2021, almost $15 billion in funding went to the digital health sector, according to a report by Rock Health. That was more than the already record-breaking numbers from the entire year of 2020. “I don’t think a lot of investors expected to double the pace of last year,” Rock...

Merck taps Evidation to use apps, wearables to detect early stages of Alzheimer’s

Merck has tapped McKesson Ventures portfolio company Evidation Health to explore whether data collected from wearables and smartphone apps can help to detect Alzheimer’s disease before visible changes in cognition take place. The companies are partnering to research whether sensor data can be used to develop digital measures to accelerate drug development for Alzheimer’s. The work builds on Evidation’s previous research on neurodegenerative disease detection from digital sensors and apps. “We know that digital measures have the potential to make visible what is currently clinically invisible. This...